ClinicalTrialsFinder

Conditions Drugs Locations Institutions Guides Search Trials Get Alerts

Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts

Conditions
Multiple Myeloma, Refractory
Durham, North Carolina

Multiple Myeloma, Refractory Clinical Trials in Durham, North Carolina

1 recruitingDurham, North Carolina

Filters

Status

RecruitingNot yet recruitingEnrolling by invitationActive, not recruiting

Sex

MaleFemale

Your Age

Shows trials you qualify for by age

Phase

Phase 1Phase 2Phase 3Phase 4Early Phase 1Not Applicable

Study Type

InterventionalObservational

Country

United StatesCanadaUnited KingdomAustraliaGermanyFranceSpainItaly

Other Locations

Hangzhou, Zhejiang2
West Hollywood, California2
Cleveland, Ohio1
Omaha, Nebraska1
Xiamen, Fujian1
Athens, Attica1
Jerusalem, Jerusalem1
Tel Aviv, Tel Aviv1
Pátrai, Achaia1
Thessaloniki, Thessaloniki1

Showing 1–1 of 1 trials

HCMT/MM2401: Ph2 Study of Selinexor + Bispecific Antibody for RRMM

Multiple Myeloma in RelapseMultiple Myeloma, Refractory

Duke University27 enrolled1 locationNCT06822972

ClinicalTrialsFinder

Helping patients and researchers find recruiting clinical trials. Updated regularly from ClinicalTrials.gov and ANZCTR.

Browse

Browse Conditions
Browse Drugs
Browse Locations
Browse Institutions
Search Trials
Get Trial Alerts

Resources

Clinical Trial Guides
FAQ
About Us
Contact
ClinicalTrials.gov
ANZCTR

Data Source

Trial data sourced from ClinicalTrials.gov and ANZCTR (Australian New Zealand Clinical Trials Registry)

Updated regularly to reflect the latest trial information

Medical Disclaimer: This site is for informational purposes only and is not a substitute for professional medical advice. Always consult your healthcare provider before making decisions about participating in a clinical trial. Trial information may change; verify details directly with the trial sponsor or at the relevant registry (ClinicalTrials.gov or ANZCTR).

© 2026 ClinicalTrialsFinder. All rights reserved.

|

Privacy Policy Terms of Service

Data provided by ClinicalTrials.gov & ANZCTR